Table 5.
Follow-up: results from phone survey.
| ICM 1 | GBCM 2 | ||
|---|---|---|---|
| Responders | (n°) | 246 | 61 |
| New exams with CM 3 | (n°, % of responders) | 141 (57) | 24 (39) |
| New HRs 4 to CM | (n°, % of pts who developed new exam) | 10 (7.1) | 2 (8.3) |
| Positive STs 5 | (n°, % of pts who developed new HR) | 0 (0) | 0 (0) |
| Negative STs | (n°, % of pts who developed new HR) | 10 (100) | 2 (100) |
| Premedication | (n°, % of pts who developed new HR) | 9 (90) | 1 (50) |
| Same culprit CM 6 | (n°, % of pts who developed new HR) | 4 (40) | 2 (100) |
1: ICM = iodinated contrast media; 2: GBCM = gadolinium-based contrast media; 3: CM = contrast media; 4: HRs = hypersensitivity reactions; 5: STs = skin tests; 6: same contrast agent involved in the first HR.